A healthy recovery: The issue facing the pharma industry
Getting the sector back in shape
Matt Crossman of Rathbones
Imagine you are a business owner and you are presented with an enormous gap in your market that needs filling and there is a dearth of competition.
But what if the products that would fill that gap are not only unprofitable, but become less valuable the more people use them? What would you do? This is the issue facing the pharmaceutical industry,...
More on ESG
Back to Top
